These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26663758)

  • 1. Anticancer Gold(III) Porphyrins Target Mitochondrial Chaperone Hsp60.
    Hu D; Liu Y; Lai YT; Tong KC; Fung YM; Lok CN; Che CM
    Angew Chem Int Ed Engl; 2016 Jan; 55(4):1387-91. PubMed ID: 26663758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergetic anticancer activity of gold porphyrin appended to phenyl tin malonate organometallic complexes.
    Nguyen C; Toubia I; Diring S; Hadj-Kaddour K; Gary-Bobo M; Kobeissi M; Odobel F
    Dalton Trans; 2021 Apr; 50(13):4583-4592. PubMed ID: 33705511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical biology of anticancer gold(III) and gold(I) complexes.
    Zou T; Lum CT; Lok CN; Zhang JJ; Che CM
    Chem Soc Rev; 2015 Dec; 44(24):8786-801. PubMed ID: 25868756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GoldIII porphyrin 1a induced apoptosis by mitochondrial death pathways related to reactive oxygen species.
    Wang Y; He QY; Sun RW; Che CM; Chiu JF
    Cancer Res; 2005 Dec; 65(24):11553-64. PubMed ID: 16357165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms and proposed targets for selected anticancer gold compounds.
    Casini A; Messori L
    Curr Top Med Chem; 2011; 11(21):2647-60. PubMed ID: 22039866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gold(III) Porphyrin-Metal-Polyphenolic Nanocomplexes: Breaking Intracellular Redox Environment for Enhancing Mild-Temperature Photothermal Therapy.
    Cui W; Zhu S; Pan X; Zhang W; Wang T
    ACS Appl Mater Interfaces; 2024 Jun; 16(24):30810-30818. PubMed ID: 38850233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pharmacological properties of gold(III) porphyrin 1a, a potential anticancer drug lead.
    Wang Y; He QY; Sun RW; Che CM; Chiu JF
    Eur J Pharmacol; 2007 Jan; 554(2-3):113-22. PubMed ID: 17116302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp60, a novel target for antitumor therapy: structure-function features and prospective drugs design.
    Pace A; Barone G; Lauria A; Martorana A; Piccionello AP; Pierro P; Terenzi A; Almerico AM; Buscemi S; Campanella C; Angileri F; Carini F; Zummo G; de Macario EC; Cappello F; Macario AJ
    Curr Pharm Des; 2013; 19(15):2757-64. PubMed ID: 23092316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effect and mechanism of a Se-modified porphyrin Au(III) complex.
    Yang FR; Li Y; Zhang XH; Wang M; Guo HR; Ruan WJ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3592-6. PubMed ID: 26152428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trilobolide-porphyrin conjugates: on synthesis and biological effects evaluation.
    Tomanová P; Rimpelová S; Jurášek M; Buděšínský M; Vejvodová L; Ruml T; Kmoníčková E; Drašar PB
    Steroids; 2015 May; 97():8-12. PubMed ID: 25204594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells.
    Soltys BJ; Gupta RS
    Exp Cell Res; 1996 Jan; 222(1):16-27. PubMed ID: 8549659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold-phosphine-porphyrin as potential metal-based theranostics.
    Tasan S; Licona C; Doulain PE; Michelin C; Gros CP; Le Gendre P; Harvey PD; Paul C; Gaiddon C; Bodio E
    J Biol Inorg Chem; 2015 Jan; 20(1):143-154. PubMed ID: 25476859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A gold(III) porphyrin complex as an anti-cancer candidate to inhibit growth of cancer-stem cells.
    Lum CT; Wong AS; Lin MC; Che CM; Sun RW
    Chem Commun (Camb); 2013 May; 49(39):4364-6. PubMed ID: 23223325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cytotoxic and cytostatic gold(III) corrole.
    Teo RD; Gray HB; Lim P; Termini J; Domeshek E; Gross Z
    Chem Commun (Camb); 2014 Nov; 50(89):13789-92. PubMed ID: 25252099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment.
    Che CM; Sun RW
    Chem Commun (Camb); 2011 Sep; 47(34):9554-60. PubMed ID: 21674082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity.
    Gianferrara T; Bratsos I; Iengo E; Milani B; Ostrić A; Spagnul C; Zangrando E; Alessio E
    Dalton Trans; 2009 Dec; (48):10742-56. PubMed ID: 20023904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of a multibranched porphyrin-oligonucleotide scaffold for the construction of DNA-based nano-architectures.
    Clavé G; Chatelain G; Filoramo A; Gasparutto D; Saint-Pierre C; Le Cam E; Piétrement O; Guérineau V; Campidelli S
    Org Biomol Chem; 2014 May; 12(17):2778-83. PubMed ID: 24668242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK; Sun RW; Kui SC; Zhu N; Che CM
    Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organogold(III) supramolecular polymers for anticancer treatment.
    Zhang JJ; Lu W; Sun RW; Che CM
    Angew Chem Int Ed Engl; 2012 May; 51(20):4882-6. PubMed ID: 22473661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.